Skip to main content
. 2016 Jun 21;22(23):5332–5341. doi: 10.3748/wjg.v22.i23.5332

Figure 1.

Figure 1

Development of cytotoxic and targeted agents for the treatment of colorectal cancer. 1KRAS wide-type patients. CRC: Colorectal cancer; 5-FU: 5-fluorouracil; LV: Leucovorin; IFL: Irinotecan + 5-fluorouracil + leucovorin; FOLFOXIRI: Leucovorin + 5-fluorouracil + oxaliplatin + irinotecan.